Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer

CORC > 兰州大学 > 兰州大学 > 基础医学院 > 期刊论文

	Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer
	Guo, L; Wu, H; Zhu, JH; Zhang, CX; Ma, JX; Lan, JF; Xie, XD
刊名	LIFE SCIENCES
	2015-12-15
卷号	143 页码:217-224
关键词	Squamous cervical cancer Neoadjuvant chemotherapy Platinum-agents Chemosensitivity
ISSN号	0024-3205
通讯作者	Xie, XD (reprint author), Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Gansu, Peoples R China.
学科主题	Research & Experimental Medicine; Pharmacology & Pharmacy
收录类别	SCIE ; PUBMED ; MEDLINE ; BIOSIS
出版地	OXFORD
语种	英语
WOS记录号	WOS:000366956600028
内容类型	期刊论文
源URL	[http://ir.lzu.edu.cn/handle/262010/179082]
专题	基础医学院_期刊论文
推荐引用方式 GB/T 7714	Guo, L,Wu, H,Zhu, JH,et al. Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer[J]. LIFE SCIENCES,2015,143:217-224.
APA	Guo, L.,Wu, H.,Zhu, JH.,Zhang, CX.,Ma, JX.,...&Xie, XD.(2015).Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer.LIFE SCIENCES,143,217-224.
MLA	Guo, L,et al."Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer".LIFE SCIENCES 143(2015):217-224.